Published in Lancet on December 13, 2004
Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res (2006) 1.54
The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion. Invest Ophthalmol Vis Sci (2011) 1.05
Gender and ocular manifestations of connective tissue diseases and systemic vasculitides. J Ophthalmol (2014) 0.83
Activation of Master Autophagy Regulator TFEB During Systemic LPS Administration in the Cornea. J Toxicol Pathol (2014) 0.78
Behcet's disease: systemic and ocular manifestations. Biomed Res Int (2013) 0.77
Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease. Autoimmune Dis (2013) 0.77
Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial. Graefes Arch Clin Exp Ophthalmol (2016) 0.77
Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies? OMICS (2015) 0.75
Traffic-related air pollution and spectacles use in schoolchildren. PLoS One (2017) 0.75
Evaluation of Ocular Surface Health in Patients with Obstructive Sleep Apnea Syndrome. Turk J Ophthalmol (2016) 0.75
Orbital and anterior visual pathway infection and inflammation. Neuroradiology (2009) 0.75
Nanomedicine approaches for corneal diseases. J Funct Biomater (2015) 0.75
[Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist]. Z Rheumatol (2008) 0.75
[Glucocorticoids: importance in the treatment of vasculitis]. Z Rheumatol (2005) 0.75
Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literature. Clin Rheumatol (2014) 0.75
The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) (2002) 2.10
Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet (2003) 1.98
Regulation of vascular smooth muscle cell differentiation. J Vasc Surg (2007) 1.92
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg (2009) 1.81
Infliximab in the treatment of refractory posterior uveitis. Ophthalmology (2003) 1.75
The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol (2003) 1.57
Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum (2003) 1.51
Carotid artery stenting and patient outcomes: the CABANA surveillance study. Catheter Cardiovasc Interv (2014) 1.45
Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling. J Biol Chem (2007) 1.35
Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: Implications for rupture risk. J Vasc Surg (2004) 1.34
Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 1.26
Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther (2004) 1.23
Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology (2004) 1.22
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition. Circ Res (2008) 1.17
Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg (2011) 1.16
Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum (2006) 1.16
Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia. J Vasc Surg (2007) 1.15
The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway. Am J Physiol Heart Circ Physiol (2006) 1.12
Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg (2009) 1.09
Mesenteric stenting for chronic mesenteric ischemia. J Vasc Surg (2005) 1.08
Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis Rheum (2004) 1.06
Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arterioscler Thromb Vasc Biol (2011) 1.05
Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes. Arthritis Rheum (2007) 1.01
Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg (2008) 1.00
Early discharge does not increase readmission or mortality after high-risk vascular surgery. J Vasc Surg (2012) 1.00
Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc Interv (2010) 1.00
Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab. Arthritis Rheum (2011) 0.99
Endovascular repair of abdominal aortic aneurysm without preoperative arteriography. J Vasc Surg (2003) 0.99
Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation. J Vasc Surg (2005) 0.96
Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus. Rheumatol Int (2003) 0.94
Outcomes of renal artery angioplasty and stenting using low-profile systems. J Vasc Surg (2005) 0.92
Prevalence and clinical significance of stent fracture and deformation following carotid artery stenting. J Vasc Surg (2011) 0.92
Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg (2011) 0.92
Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease. J Vasc Surg (2011) 0.91
Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line. Arthritis Rheum (2009) 0.91
A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS). Eur J Immunol (2014) 0.90
Disseminated Mycobacterium tuberculosis infection due to interferon gamma deficiency. Response to replacement therapy. Thorax (2007) 0.89
Current status of carotid artery stenting. J Vasc Surg (2006) 0.89
Early results of stent-grafting to treat diffuse aortoiliac occlusive disease. J Vasc Surg (2003) 0.88
A truncated plasminogen activator inhibitor-1 protein blocks the availability of heparin-binding vascular endothelial growth factor A isoforms. J Biol Chem (2002) 0.87
Blinded comparison of preoperative duplex ultrasound scanning and contrast arteriography for planning revascularization at the level of the tibia. J Vasc Surg (2003) 0.86
Hyperoxia enhances VEGF release from A549 cells via post-transcriptional processes. Free Radic Biol Med (2007) 0.86
Human autologous mixed lymphocyte reaction as an in vitro model for autoreactivity to apoptotic antigens. Immunology (2002) 0.85
Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss. Acta Otolaryngol (2005) 0.85
"Medical high risk" designation is not associated with survival after carotid artery stenting. J Vasc Surg (2007) 0.85
Shifting Wallgraft position: case reports and review of the forces affecting Wallgraft positioning. J Vasc Surg (2006) 0.84
Carotid artery stenting: what have we learned from the clinical trials and registries and where do we go from here? Ann Vasc Surg (2008) 0.84
Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR. Am J Physiol Cell Physiol (2010) 0.84
Brain injury after carotid revascularization: outcomes, mechanisms, and opportunities for improvement. Ann Vasc Surg (2010) 0.83
Hyperoxia alters the expression and phosphorylation of multiple factors regulating translation initiation. Am J Physiol Lung Cell Mol Physiol (2004) 0.83
Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum (2007) 0.83
Early results of external iliac artery stenting combined with common femoral artery endarterectomy. J Vasc Surg (2002) 0.82
Restenosis in gold-coated renal artery stents. J Vasc Surg (2005) 0.82
Functional outcomes following catheter-based iliac vein stent placement. Vasc Endovascular Surg (2013) 0.82
The value of 3D-CT angiographic assessment prior to carotid stenting. J Vasc Surg (2009) 0.82
The impact of adjunctive iliac stenting on femoral-femoral bypass in contemporary practice. J Vasc Surg (2012) 0.81
Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation. J Mol Cell Cardiol (2009) 0.81
Lean principles optimize on-time vascular surgery operating room starts and decrease resident work hours. J Vasc Surg (2013) 0.81
Internal iliac occlusion without coil embolization during endovascular abdominal aortic aneurysm repair. J Vasc Surg (2002) 0.81
Cost determinants of percutaneous and surgical interventions for treatment of intermittent claudication from the perspective of the hospital. Cardiovasc Intervent Radiol (2007) 0.80
The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration. J Vasc Surg (2002) 0.80
Prediction of early graft failure with intraoperative completion duplex ultrasound scan. J Vasc Surg (2002) 0.77
Management of carotid injuries in a hostile neck using endovascular grafts. J Vasc Surg (2004) 0.75
Clinical effectiveness of secondary interventions for restenosis after renal artery stenting. J Vasc Surg (2013) 0.75
Retrospective review of superficial femoral artery stenting in diabetic patients: thiazolidinedione use may decrease reinterventions. BMC Cardiovasc Disord (2014) 0.75
Heterogeneity of tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Siebert et al. Arthritis Rheum (2005) 0.75
Stent graft repair of iatrogenic femoral arteriovenous fistula: a useful therapeutic approach in a hostile groin. Vasc Endovascular Surg (2009) 0.75
Embolic stroke after carotid stenting: microscopic computed tomography analysis of en bloc surgical specimen demonstrating ulceration. Circulation (2010) 0.75